 | Zacks: Analysts Expect Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Will Announce Earnings of -$0.80 Per Share
www.americanbankingnews.com - June 23 at 7:10 AM |
| Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 23 at 2:37 AM |
| Short Interest in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Expands By 9.3%
www.americanbankingnews.com - June 20 at 10:16 PM |
 | Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors
finance.yahoo.com - June 19 at 5:35 PM |
| Insider Selling: Rhythm Pharmaceuticals Inc (RYTM) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - June 3 at 5:15 PM |
| -$0.80 EPS Expected for Rhythm Pharmaceuticals Inc (RYTM) This Quarter
www.americanbankingnews.com - May 31 at 12:19 PM |
| Der Ploeg Leonardus H.T. Van Sells 15,000 Shares of Rhythm Pharmaceuticals Inc (RYTM) Stock
www.americanbankingnews.com - May 30 at 5:20 PM |
 | Why Q3 Is Critical For Rhythm Pharmaceuticals
seekingalpha.com - May 22 at 10:08 AM |
| Here’s What Hedge Funds Think About Rhythm Pharmaceuticals, Inc. (RYTM)
finance.yahoo.com - May 7 at 5:33 PM |
| Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference
finance.yahoo.com - May 7 at 10:06 AM |
| Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 3 at 10:18 AM |
| If You Had Bought Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock A Year Ago, You Could Pocket A 10% Gain Today
finance.yahoo.com - April 26 at 5:21 PM |
 | X4 Pharmaceuticals Appoints Murray W. Stewart, M.D. to Board of Directors
www.businesswire.com - April 2 at 1:06 PM |
| Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference
finance.yahoo.com - April 2 at 1:06 PM |
| Rhythm Pharma's setmelanotide shows positive action in mid-stage obesity study
seekingalpha.com - March 28 at 10:38 AM |
| Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
finance.yahoo.com - March 28 at 10:38 AM |
 | Global Anti-Obesity Therapeutics Market Outlook, Key Trends, Opportunities, Product Quality, Competitive Analysis and Forecast 2019-2028
www.marketwatch.com - March 22 at 10:31 AM |
| Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 8 at 10:39 AM |
| Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference
finance.yahoo.com - March 4 at 9:52 AM |
| Rhythm Pharmaceuticals: Opportunity To Take Position Ahead Of Pivotal Data
seekingalpha.com - February 1 at 10:25 AM |
| A Look At The Fair Value Of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
finance.yahoo.com - January 25 at 4:42 PM |
 | RYTM Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - January 24 at 10:27 AM |
| Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 8:21 AM |
| Bullish Two Hundred Day Moving Average Cross - RYTM
www.nasdaq.com - December 31 at 4:09 PM |
| Rhythm Pharmaceuticals enrolls first patient in phase 3 trial evaluating setmelanotide in BBS and Alström Syndrome
seekingalpha.com - December 13 at 8:41 AM |
| Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
finance.yahoo.com - December 13 at 8:41 AM |
| Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome
finance.yahoo.com - December 6 at 9:44 AM |
| Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
finance.yahoo.com - November 15 at 9:40 AM |
| Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 9 at 10:06 AM |
| Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 9:58 AM |
| Rhythm Pharmaceuticals appoints Murray W. Stewart as Chief Medical Officer
seekingalpha.com - October 15 at 9:29 AM |
| Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer
finance.yahoo.com - October 15 at 9:29 AM |
| This Day That Year: Rhythm Pharma
www.nasdaq.com - October 5 at 9:38 AM |
| Commit To Purchase Rhythm Pharmaceuticals At $25, Earn 18.5% Annualized Using Options
www.nasdaq.com - October 3 at 4:00 PM |
 | Rhythm Pharmaceuticals (RYTM) Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide
www.streetinsider.com - September 28 at 4:04 PM |
 | Updated data show continued reductions in body weight and decreased appetite in patients with rare genetic disorders of obesity
globenewswire.com - September 28 at 9:43 AM |
| Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome at 57th Annual ESPE Meeting
finance.yahoo.com - September 28 at 9:43 AM |
| Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
finance.yahoo.com - September 28 at 9:43 AM |
| Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference
finance.yahoo.com - September 25 at 9:45 AM |
| Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 9:42 AM |
| Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 9 at 10:09 AM |
| Rhythm Pharmaceuticals (RYTM) Receives EMA PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
www.streetinsider.com - July 24 at 10:12 AM |
| Rhythm Pharma's setmelanotide a PRIME drug in Europe for rare genetic disorders of obesity
seekingalpha.com - July 23 at 3:45 PM |
| Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
finance.yahoo.com - July 23 at 9:38 AM |
| Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 25 at 4:03 PM |
| Here's Why Rhythm Pharmaceuticals Inc Rose as Much as 37% Today
finance.yahoo.com - June 21 at 4:03 PM |
 | Here's Why Rhythm Pharmaceuticals Inc Rose as Much as 37% Today
www.fool.com - June 21 at 3:46 PM |
| Rhythm Pharmaceuticals announces pricing of public offering
seekingalpha.com - June 21 at 11:32 AM |
| Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
finance.yahoo.com - June 21 at 11:32 AM |
 | Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder
www.bizjournals.com - June 19 at 12:01 PM |
